Eli Lilly & Co.
Cash Flow Statement
| Line Item | FY2009 | FY2008 | FY2007 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $4.33B | $-2.07B | $2.95B |
| Depreciation & Amortization | $1.30B | $1.12B | $-1.05B |
| Depreciation | $813.5M | $731.7M | — |
| Amortization | $277.0M | $193.4M | — |
| Stock-Based Compensation | $368.5M | $255.3M | $-282.0M |
| Net Cash from Operating Activities | $4.34B | $7.30B | $5.15B |
| Investing Activities | |||
| Capital Expenditures | $765.0M | $947.2M | $1.08B |
| Business Acquisitions | $0 | $6.08B | $2.67B |
| Net Cash from Investing Activities | $142.8M | $-7.27B | $-4.33B |
| Financing Activities | |||
| Dividends Paid | $2.15B | $2.06B | $1.85B |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $-5.53B | $2.35B | $-844.9M |
| Net Change in Cash | $-1.03B | $2.28B | $111.2M |
| Free Cash Flow | $3.57B | $6.35B | $4.07B |